Genflow Biosciences (LON:GENF) Issues Earnings Results

Genflow Biosciences (LON:GENF) issued its quarterly earnings results on Thursday. The company reported GBX (0.33) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Genflow Biosciences had a net margin of 840.76% and a return on equity of 377.33%.

Genflow Biosciences Stock Down 7.7%

LON:GENF opened at GBX 2.56 on Friday. Genflow Biosciences has a twelve month low of GBX 0.55 and a twelve month high of GBX 3.12. The stock’s 50-day simple moving average is GBX 2.06 and its 200 day simple moving average is GBX 1.98. The firm has a market capitalization of £13.69 million, a PE ratio of -5.09 and a beta of 2.11.

Genflow Biosciences Company Profile

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.